Faltblatt - 5th Abdominal Metastatic Cancer.indd
Faltblatt - 5th Abdominal Metastatic Cancer.indd
Faltblatt - 5th Abdominal Metastatic Cancer.indd
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Speakers<br />
Prof. Dr. Dirk Arnold<br />
Innere Medizin IV<br />
Hubertus Wald Tumorzentrum - Universitäres <strong>Cancer</strong> Center, Hamburg<br />
Prof. Dr. Jan Braess<br />
Hämatologie/Onkologie, KH Barmherzige Brüder, Regensburg<br />
Prof. Dr. Björn Brücher<br />
Viszeral- und Transplantationschirurgie<br />
Universitätsklinik für Allgemeine, Tübingen<br />
Dr. Philipp von Breitenbuch<br />
Chirurgie, Universitätsklinikum Regensburg, Regensburg<br />
PD Dr. Marc Dahlke<br />
Chirurgie, Universitätsklinikum Regensburg, Regensburg<br />
Dr. Jesus Esquivel<br />
Peritoneal Surface Malignancy Program<br />
St. Agnes Hospital Baltimore, MD Maryland, USA<br />
Prof. Dr. F. N. Gilly<br />
Centre hospitalier universitaire Lyon-Sud<br />
Service de chirurgie viscérale et thoracique, Pierre-Bénite, France<br />
Dr. Gabriel Glockzin<br />
Chirurgie, Universitätsklinikum Regensburg, Regensburg<br />
Prof. Dr. C. William Helm<br />
Division of Gynec. Oncology, University of Louisville, USA<br />
Prof. Dr. Joachim Jähne<br />
Chirurgisches Zentrum, Henriettenstiftung, Hannover<br />
Prof. Dr. Björn Lampe<br />
Klinik für Gynäkologie, Florence-Nightingale-Krankenhaus, Düsseldorf<br />
Prof. Dr. Hauke Lang<br />
Allgemein- und <strong>Abdominal</strong>chirurgie,<br />
Johannes Gutenberg-Universität, Mainz<br />
PD Dr. Martin Loss<br />
Chirurgie, Universitätsklinikum Regensburg, Regensburg<br />
Dr. Max Mayr<br />
Chirurgie, KH Barmherzige Brüder, Regensburg<br />
Prof. Dr. David Morris<br />
St. George Hospital University of Sydney, UNSW Kogarah NSW, Australia<br />
Prof. Dr. Karl-Jürgen Oldhafer<br />
Allg.- und Viszeralchirurgie, Asklepios Klinik Barmbeck, Hamburg<br />
PD Dr. Jörg Pelz<br />
Chirurgische Klinik I, Universitätsklinikum Würzburg, Würzburg<br />
Prof. Dr. Pompiliu Piso<br />
Chirurgie, KH Barmherzige Brüder, Regensburg<br />
Prof. Dr. Beate Rau<br />
Chirurgie, Charité Campus Mitte Berlin, Berlin<br />
Prof. Dr. Hans J. Schlitt<br />
Chirurgie, Universitätsklinikum, Regensburg<br />
Prof. Dr. Birgit Seelbach-Göbel<br />
Klinik für Frauenheilkunde und Geburtshilfe der Universität Regensburg<br />
Krankenhaus der Barmherzigen Brüder - Klinik St. Hedwig<br />
Prof. P. H. Sugarbaker<br />
Oncology Associates,<br />
Washington Hospital Center, Washington D.C. , USA<br />
Prof. Dr. Christian Stroszczynski<br />
Institut für Röntgendiagnostik<br />
Universitätsklinikum Regensburg, Regensburg<br />
Prof. Dr. Karl-Herrmann Wiedmann<br />
Medizinische Klinik, KH Barmherzige Brüder, Regensburg<br />
General Information/Organization<br />
Scientific and Organizing Committee<br />
Prof. Dr. P. Piso<br />
Prof. Dr. H. J. Schlitt<br />
Congress Venue<br />
Krankenhaus Barmherzige Brüder<br />
(St. John of God Hospital)<br />
Congress Secretary<br />
Irmgard Scheruebl<br />
University Hospital<br />
Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany<br />
Phone +49 941 944 6837<br />
Fax +49 941 944 6838<br />
e-mail kongresse@klinik.uni-regensburg.de<br />
Internet http://www.uniklinikum-regensburg.de<br />
Registration fee: 150 € (both days)<br />
110 € (monday) / 75 € (tuesday)<br />
Bavarian evening: July 4, 2011, Dinner charges 45€<br />
Payment via Bank account:<br />
Universitätsklinikum Regensburg<br />
Bank code 750 500 00 Account No. 780 010 500<br />
IBAN-Nr. DE52750500000780010500 Swift-Code BYLADEM1RBG<br />
Project No. 374 42 20 (please quote)<br />
Main Sponsors:<br />
ThermaSolutions<br />
Covidien Deutschland GmbH<br />
Roche Pharma AG<br />
Merck Pharma Deutschland GmbH<br />
Vielberth Stiftung<br />
RAND S.r.l.<br />
Sponsors:<br />
Baxter Deutschland GmbH<br />
Bayer Vital GmbH<br />
Codan pvb Medical GmbH<br />
gd medical ag/Belmont Instrument HIPEC<br />
Johnson & Johnson Medical GmbH<br />
MSD Sharp & Dohme GmbH<br />
Nycomed Deutschland GmbH<br />
Sanofi -Aventis Deutschland GmbH<br />
Tutogen Medical GmbH<br />
<strong>5th</strong> International Symposium on<br />
<strong>Abdominal</strong> <strong>Metastatic</strong> <strong>Cancer</strong><br />
KH Barmherzige Brüder, Regensburg<br />
Universitätsklinikum Regensburg<br />
4th - <strong>5th</strong> of July, 2011<br />
Regensburg
Dear colleagues,<br />
it is a great pleasure and honour to invite you<br />
to our <strong>5th</strong> International Symposium on Metastastatic<br />
<strong>Abdominal</strong> <strong>Cancer</strong> in Regensburg. This<br />
year, management of liver metastases has been<br />
integrated into the scientific program. There<br />
are many aspects suggesting that both liver and<br />
peritoneal metastases may be treated in similar<br />
fashion with comparable long-term results. A<br />
live-operation and many free papers will be added<br />
to the present symposium. Opinion-leaders<br />
from three continents will give us an insight into<br />
their broad experience.<br />
Many medical centers in Germany do manage<br />
metastastic abdominal cancer by multimodality<br />
treatment strategies including major cytoreductive<br />
surgery. We are proud to announce that the<br />
German groups are organizing the next World<br />
Congress on Peritoneal Surface Malignancies<br />
which will be held in October 2012 in Berlin.<br />
Last but not least, the City of Regensburg,<br />
UNESCO heritage, will delight you with its Mediterranean<br />
flair in an excellent preserved middle<br />
age city. For the first time, the congress venue<br />
will be the Saint John of God Hospital in Regensburg,<br />
the largest Catholic hospital in Germany.<br />
We are looking forward meeting you in Regensburg<br />
and remain<br />
With best regards<br />
P. Piso H. J. Schlitt<br />
Program<br />
Monday 04.07.2011<br />
During the sessions short breaks for live-transmission from<br />
the Operation Room , KH Barmherzige Brüder<br />
09:00 - 11:00 Session 1<br />
Chairman: Piso, Regensburg; Braess, Regensburg<br />
09:00 - 09:30 What is the maximum prognostic benefit we can achieve<br />
for patients with liver or peritoneal metastases ?<br />
Gilly, France<br />
09:30 - 10:00 Selection criteria for surgical treatment of<br />
liver metastases<br />
Morris, Australia<br />
10:00 - 10:30 Combination of liver resection with regional chemotherapy<br />
and/or radiofrequency ablation<br />
Morris, Australia<br />
10:30 - 11:00 Peritoperative chemotherapy for colorectal<br />
liver metastases<br />
Arnold, Hamburg<br />
11:00 – 11:30 Coffee Break and sponsor visiting<br />
11:30 – 13:00 Session 2<br />
Chairman: Schlitt, Regensburg; Wiedmann, Regensburg<br />
11:30 - 12:00 Surgical technique of liver resection (with video)<br />
Oldhafer, Hamburg<br />
12:00 - 12:30 Delayed two-stage liver resection for bilateral<br />
liver metastases<br />
Schlitt, Regensburg<br />
12:30 - 13:00 Case reports discussed in a pannel of experts<br />
Lang, Mainz (moderator)<br />
13:00 – 14:00 Lunch and sponsor visiting<br />
14:00 – 15:30 Session 3<br />
Chairman: Loss, Regensburg; Glockzin, Regensburg<br />
Free papers<br />
15:30 – 16:00 Coffee Break and sponsor visiting<br />
16:00 – 18:00 Session 4<br />
Chairman: Jähne, Hannover; Esquivel, USA<br />
16:00 - 16:30 Selection criteria for treatment of patients<br />
with peritoneal carcinomatosis<br />
Esquivel, USA<br />
16:30 - 17:00 Case presentations<br />
Sugarbaker/Morris/Piso/Esquivel<br />
17:00 - 17:30 Perioperative chemotherapy for<br />
peritoneal carcinomatosis<br />
Braess, Regensburg<br />
17:30 - 18:00 Update on ongoing trials<br />
Gilly/Esquivel/Piso<br />
19:00 Bavarian evening<br />
Tuesday 05.07.2011<br />
09:00 - 11:00 Session 5<br />
Chairman: Brücher, Tübingen; v. Breitenbuch, Regensburg<br />
09:00 - 09:40 Extended indications for CRS and HIPEC<br />
Sugarbaker, USA<br />
09:40 - 10:25 How to start a PC program<br />
Morris, Australia<br />
10:25 - 11:00 Costs-analysis related to CRS and HIPEC<br />
Rau, Berlin<br />
11:00 – 11:30 Coffee Break and sponsor visiting<br />
11:30 - 13:00 Session 6<br />
Chairman: Pelz, Würzburg; Seelbach-Göbel, Regensburg<br />
11:30 - 12:00 Limiting factors for complete cytoreduction for<br />
ovarian cancer with peritoneal carcinomatosis<br />
Lampe, Düsseldorf<br />
12:00 - 12:30 Ovarian <strong>Cancer</strong> - HIPEC and Maximal Surgery.<br />
The Time is Now<br />
Helm, USA<br />
12:30 - 13:00 Morbidity and mortality after CRS and HIPEC –<br />
Pannel of discussions<br />
Piso, Regensburg<br />
13:00 – 14:00 Lunch and sponsor visiting<br />
14:00 – 15:30 Session 7<br />
Chairman: Dahlke, Regensburg; Mayr, Regensburg<br />
14:00 - 14:30 Devices for long-term intraperitoneal<br />
chemotherapy<br />
Sugarbaker, USA<br />
14:30 - 15:00 Best investigation modalities for liver and<br />
peritoneal metastases<br />
Stroszczynski, Regensburg<br />
15:00 - 15:30 Recommendations for the general practitioner<br />
regarding the algorithm after primary diagnosis<br />
of metastases<br />
Schlitt/Piso, Regensburg<br />
16:00 End of the meeting<br />
Das Symposium wird von der BLÄK mit<br />
15 Fortbildungspunkten bewertet.
Change language